Status:
COMPLETED
Innate Immune Response of Blood Cells in Patients With Pneumonia
Lead Sponsor:
Lille Catholic University
Collaborating Sponsors:
Institut Pasteur de Lille
Conditions:
Lobar Pneumonia
Eligibility:
All Genders
18+ years
Brief Summary
Pulmonary bacterial infections such as exacerbations of chronic bronchitis, nosocomial and community-acquired pneumonia represent a major public health issue. Antibiotics have shown their efficacy by ...
Eligibility Criteria
Inclusion
- Adult patient hospitalized in the department of pneumology for whom clinical, radiological and biological criteria confirm the diagnosis of lobar pneumonia
- Beneficiary of the French National Health Insurance Fund
- Signed informed consent form
Exclusion
- Patient under guardianship
- Patient with acute respiratory distress syndrome or septic shock
- Pregnant women
- Patient with HIV, HCV or Mycobacterium tuberculosis
- Transplanted patient receiving immunosuppressive therapy
Key Trial Info
Start Date :
October 20 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 24 2020
Estimated Enrollment :
37 Patients enrolled
Trial Details
Trial ID
NCT03231670
Start Date
October 20 2017
End Date
June 24 2020
Last Update
March 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Saint-Philibert
Lomme, Hauts-de-France, France, 59000